SARS-CoV-2 Diagnostics Testing: Critical Role in the Pandemic

about hubXCHANGE

Offering a unique and high-level platform for executives to engage and network

Accelerating growth across industry

HubXchange was created in response to feedback from executives attending conferences who bemoaned the inadequate opportunities to engage and network with peers at their level. With more than 20 years of experience in the conference sector across the Life Sciences and other markets, hubXchange is well-placed to respond to this need and offer a unique and high-level platform for executives to engage and network with each other.

Office workers in a business meeting in an office

You need a plan to succeed

hubXchange is proud and delighted to have hosted this webinar on June 3rd. The expert panel, moderated by John Sninsky, explored the challenges of SARS-CoV-2 testing and proposed a few important next steps including:

As the world experiences unprecedented restrictions and confinement due to the SARS-Cov-2 pandemic, diagnostic testing, treatment alternatives and vaccine strategies are equally critical for different reasons. Diagnostic testing has multiple roles: identify infected people, determine efficacy of treatment, suppress local outbreaks through case tracking, identify those who have been exposed and those who may have partial immunity to consider for convalescent sera and efficacy of vaccines. 

Set against this backdrop, hubXchange wants to play its part in the fight against SARS-CoV-2 by hosting this free webinar panel discussion to serve as a beacon of clarity for the Life Sciences community. We intend for the webinar to be an unbiased, constructive and informative forum by bringing together a highly experienced group of experts to offer their critique of the existing tests for the various intended uses and collectively address the challenges we continue to face and how we might better prepare for the future. 

You can watch to the recording of this webinar below:

A computer, laptop, notebook and pen
Play Video
Learn more about our agenda

12:00pm Interpretation of Diagnostic Test Results

12:20pm Direct Detection of Virus

12:50pm Detection of Viral Exposure (Serology)

1:20-1:30pm Q&A

Our Expert Panel